Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA extends approval of Lundbeck's Sabril

Oct. 29, 2013

Amorfix Life Sciences detects misfolded SOD1 in sporadic ALS

Oct. 29, 2013

Columbia University prepares new ferroptosis modulators

Oct. 29, 2013

Cells of a patient with Unverricht-Lundborg disease corrected for splice defect

Oct. 29, 2013

Pharmacological and behavioral characterization of a murine model of chronic migraine

Oct. 29, 2013

EMA committee recommends approval of Lundbeck's Brintellix

Oct. 28, 2013

Zohydro ER approved by the FDA for pain

Oct. 28, 2013

New chimeric/humanized antibodies bind to human tau protein

Oct. 28, 2013

Novel stem cell microparticles claimed by ReNeuron

Oct. 28, 2013

FDA approves GE Healthcare's brain imaging drug for Alzheimer's disease and dementia

Oct. 28, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...